none | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.

All posts in none

Early Registration Discount Ends July 27th

Early Registration Deadline Extended!

Discounted registration rates are available through Thursday, July 27th. Register Now, to take advantage of this offer before it expires.

Pharma $ 750 (early) / $1080 (regular)

Startup $ 550 (early) / $660 (regular)

Academic/Non-profit $350 (early)/ $480 (regular)

Student/Post-doc/Retiree $150 (early)/ $200 (regular)

Vendor/Peptide Manufacturer $1800 (early and regular)

Live 4-day event: September 18-21, 2023, Napa Valley Marriott, Napa, CA

In addition to the lectures, workshops, and panel discussion, the registration fee includes breakfasts (3), lunches (4), a Welcome Reception, Poster Reception, and the Gala Dinner.

Dr. Helena Safavi is awarded the 2023 Young Investigator Award

June 29, 2023 (Boulder, CO)  -   Dr. Helena SafaviThe Boulder Peptide Society is pleased to announce that Dr. Helena Safavi, at the University of Utah in Salt Lake City, has received the Young Investigator Award for 2023.  The Young Investigator Award was established in 2016 to support promising peptide scientists early in their career. 

Helena Safavi is an Associate Professor of Biochemistry at the University of Utah in Salt Lake City. Dr. Safavi studied biology at the University of Cologne (Germany) and the Australian Institute of Marine Sciences in Townsville (Australia). She obtained her PhD in Biochemistry and Molecular Biology at the University of Melbourne (Australia) in 2011 where she was trained in the transcriptomics and proteomics identification of bioactive peptides from animal venoms under the supervision of Prof. Anthony Purcell. Following her PhD studies Dr. Safavi received a Marie Curie Postdoctoral Fellowship to conduct a joined research project on the large-scale identification and biomedical characterization of peptide toxins and biosynthetic enzymes with Lars Ellgaard at the University of Copenhagen (Denmark) and Toto Olivera at the University of Utah (USA). During this time, she discovered that predatory cone snails use insulin-like toxins to induce dangerously low blood sugar in their fish prey, a discovery that inspired the design of new fast-acting insulin drug leads for the treatment of diabetes.

.

Having had broad training in the characterization of bioactive peptides from animal venoms, Dr. Safavi's independent research focuses on the identification of hormone-like toxins as drug leads for the treatment of diabetes and pain. Her group’s recent findings on a novel class of somatostatin-like toxins elucidated an ancient origin of the somatostatin signaling system in animals and has led to the design of several stable and selective somatostatin analogs that provide analgesia in mouse models of acute and chronic pain.


In recognition of her professional and scientific achievements, the Scientific Advisory Board of the Boulder Peptide Society is pleased to present the award to Helena Safavi. Dr. Savafi will present an oral presentation on her research and formally accept the award at the fall Boulder Peptide Symposium Sept 18-21, 2023 in Napa Valley, California.

For more information visit www.boulderpeptide.org

 

Sussex Research Laboratories Inc.

Company

Sussex Research Laboratories Inc. is a global leader in the areas of glycopeptide and carbohydrate synthesis. We are a trusted producer of high-quality reagents for both research and drug discovery for over 25 years. Our customers range from small academic university labs to large multinational drug discovery companies.

We have an extensive catalog of glycopeptides including mucin glycopeptides (e.g., MUC1, MUC2, MUC3A, MUC4, MUC5AC, MUC7, and MUC16), erythropoietin analogues, Frizzled 8 analogues, and IgA hinge region peptides. Our core services include but are not limited to custom glycopeptide and peptide synthesis, glycopeptide libraries, glycoamino acids, glycopolypeptides, glycan-based targeting ligands (e.g., GalNAc-ASGPR, Siglecs, Selectins, and Galectins). We manufacture all of our products at our flagship location in Ottawa, Ontario, Canada and most recently opened a new location in San Diego, California, USA.

We are passionate and engaged scientists who truly care about each client’s needs, our relationships with our clients and the quality of our customer service. www.sussex-research.com

CONTACT

location_on100 Sussex Drive, Suite 1120B, Ottawa, Ontario, K1A 0R6, Canada

local_phone613-883-4402

BCN Peptides

Company

BCN Peptides is completely focused on the cGMP manufacture of Bioactive Peptides for Pharmaceutical and Veterinary applications.

Located in Barcelona area (Spain) and operating since 1990, we concentrate our efforts in the following activities:
• cGMP Synthesis of Bulk Generic Peptides.
• Custom Synthesis of proprietary API Peptides.
• NeoAntigen Peptides for Personalized Medicine.
• Proprietary R&D Products

Our brand new custom-design facility allows us to be one of the leading companies into the GMP manufacture of bioactive peptides with a manufacturing capacity of more than 400kg/year of GMP Peptide using SPPS technology.

Excellent GMP compliance: PMDA, US-FDA and EDQM Approved. BCN Peptides Manufactures from milligrams up to the Bulk Quantities required for commercialization

Furthermore, BCN Peptides R&D department develops therapeutically promising peptides in order to solve unmet needs on different indications, such as: neuropathic and inflammatory pain, diabetic retinopathy or autoimmune diseases. www.bcnpeptides.com/

CONTACT

BCN Peptides

location_onPoligon Industrial Els Vinyets-Els Fogars II, 08777 Sant Quintí de Mediona, Barcelona - Spain

local_phone+34 93 819 13 99

contact_mailinfo@bcnpeptides.com

CSBio

Welcome to CSBio

CSBio is a leading peptide and instrumentation manufacturing company located in Silicon Valley, California. Since it's founding in 1993, CSBio has been providing automated peptide synthesizers to the global pharmaceutical community, that includes academic institutions, pharmaceutical companies, and peptide CDMOs (contract development and manufacturing organization). CSBio also produces high quality custom peptides and cGMP peptides as a peptide CDMO. Our peptide products and instrumentation can be found in production laboratories and pharmaceutical companies worldwide.

USA Headquarters

location_onCSBio, 20 Kelly Court, Menlo Park, CA 94025

contact_mailpeptides@csbio.com

local_phone(650)-322-1111

(650)-525-6200

NanoMicro

Company

NanoMicro is the world leader in the manufacture of spherical, mono-disperse particles utilizing our proprietary manufacturing processes which enable high yield, cost effective production of such particles for a wide variety of industries and applications. NanoMicro`s products cover a broad spectrum of applications including high performance Chromatography Media, solid phase extraction (SPE) sorbents, Particle Size Standards,Magnetic Particles, LCD Spacers, ACF Conductive Particles, and various other micro particles.

Our chromatography products are available in a variety of polymer formats with particle sizes from analytical through to preparative scale. Our proprietary expertise in controlling particle morphology and surface chemistry can be precisely tailored to optimize for solutes ranging from the smallest API to large constructs such as viruses and viral vectors. A wide range of surface chemistries is available from RPC/chiral for small molecules to ion exchange/affinity for biomolecules.

We manufacture mono-disperse particles of wide range of sizes. With more than 10 product lines and over 5000 products, we serve a variety of rapidly growing industry segments.

NanoMicro has two ISO 9001-certified manufacturing sites, one in Suzhou Industrial Park and another in Changshu to ensure security of supply for our customers. Both facilities use the same well- defined processes with production capacity of more than 200,000 Liter of resins and 24,000 kg of silica products per year with batch sizes up to 1000 L or 200 kg. NanoMicro`s manufacturing and quality system are available for customer audits.

Additionally, our strong R&D and applications teams ensure sustainable innovation and can provide custom solutions such as custom resin development and purification process development.https://www.nanomicro-technology.com/suzhou-nanomicro-technology-co-ltd.html

There’s Still Time to Submit a Poster Abstract for BPS 2022!

Call for BPS 2022 Poster Abstracts has been extended to October 15, 2022. Submit your poster today at boulderpeptide.org.

Prizes for this year's symposium are: $1,000 for 1st; $500 for 2nd; and $250 for 3rd place.

*Free* Virtual BPS on Development of PCSK9 Inhibitor Peptides: Aug 2nd

The August BPF Virtual Symposium will feature Chengwei Wu and Li Li, both from Merck Research Laboratories espeaking on different aspects of the development of PCSK9 inhibitor peptides. Each speaker will present for 30 minutes followed by a moderated panel discussion when attendees will have a chance to submit and ask questions.

Registration is free, and can be completed at Virtual BPS | Boulder Peptide Symposium. *Note* you must be signed in to the site inorder to sign up.

These educational e-seminars are provided free of charge by the Boulder Peptide Foundation. If your company is interested in supporting this or other educational initiatives, please email sponsorship@boulderpeptide.org.

Video Recordings Available for VBPS on Peptides Targeting GPCRs

Missed seeing the May VBPS event on GPCR Targeting?  Have no fear, the videos are here!

On May 4th,  Sally Liang Wang, of Peplib, and Peter McNamara, of Tectonic Therapeutics, each gave a talk on how their companies are targeting GPCRs with peptide therapeutics. Each speaker will presented for 30 minutes followed by a moderated panel discussion and Q&A session.

Recordings of the seminar are available at www.boulderpeptide.org/virtual-bps/. *Please note - you must be logged in to the Boulder Peptide website to access the link*

These educational e-seminars are provided free of charge by the Boulder Peptide Foundation. If your company is interested in supporting this or other educational initiatives, please email sponsorship@boulderpeptide.org.


s2Member®
loading...